iBio sets 2026 shareholder meeting and deadlines
iBio, Inc. plans to hold its 2026 Annual Meeting of Stockholders on October 14, 2026, with stockholders of record at the close of business on September 1, 2026 entitled to vote.
Rhea-AI Filing Summary
iBio, Inc. plans to hold its 2026 Annual Meeting of Stockholders on October 14, 2026, with stockholders of record at the close of business on September 1, 2026 entitled to vote. The specific time and location will be provided in the definitive proxy statement.
Because this meeting date is more than 30 days earlier than the 2025 annual meeting, previously disclosed proposal deadlines no longer apply. Stockholder proposals for inclusion in the proxy materials under Rule 14a-8 must be received by August 1, 2026. Proposals or director nominations not under Rule 14a-8, submitted under the company’s bylaws, must be received by July 27, 2026. To comply with universal proxy rules, stockholders soliciting proxies for alternative director nominees must provide the notice required by Rule 14a-19 by August 15, 2026, 60 days before the meeting date.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
Rule 14a-8 regulatory
Second Amended and Restated Bylaws regulatory
universal proxy rules regulatory
Rule 14a-19 regulatory
record date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When is iBio (IBIO) holding its 2026 Annual Meeting of Stockholders?
What is the record date for voting at iBio (IBIO)'s 2026 Annual Meeting?
What is the deadline for non-Rule 14a-8 proposals or nominations at iBio (IBIO)?
What are iBio (IBIO)'s universal proxy notice requirements for 2026 director nominees?
Why did iBio (IBIO) reset its previously disclosed 2026 proposal deadlines?
AI-generated analysis. How Rhea-AI works. Not financial advice.